Other equities research analysts have also issued research reports about the stock. BMO Capital Markets set a $78.00 target price on shares of Zoetis and gave the company a hold rating in a research note on Thursday. UBS Group restated a neutral rating on shares of Zoetis in a research note on Friday, November 24th. BidaskClub lowered shares of Zoetis from a hold rating to a sell rating in a research note on Wednesday, November 1st. Zacks Investment Research lowered shares of Zoetis from a buy rating to a hold rating in a research note on Wednesday, November 1st. Finally, Stifel Nicolaus restated a buy rating and issued a $65.00 target price on shares of Zoetis in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company’s stock. Zoetis has a consensus rating of Buy and a consensus target price of $80.00.
Zoetis (ZTS) opened at $79.73 on Thursday. The company has a debt-to-equity ratio of 2.45, a current ratio of 2.80 and a quick ratio of 1.95. The firm has a market cap of $38,850.00, a PE ratio of 36.57, a price-to-earnings-growth ratio of 1.69 and a beta of 1.07. Zoetis has a 12-month low of $52.25 and a 12-month high of $81.40.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Investors of record on Friday, April 20th will be paid a dividend of $0.126 per share. The ex-dividend date is Thursday, April 19th. This represents a $0.50 annualized dividend and a yield of 0.63%. Zoetis’s dividend payout ratio (DPR) is 22.94%.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in ZTS. Shelton Capital Management acquired a new stake in Zoetis during the second quarter worth about $232,000. Arrowstreet Capital Limited Partnership acquired a new stake in Zoetis during the second quarter worth about $917,000. Raymond James Financial Services Advisors Inc. raised its stake in Zoetis by 51.4% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 31,041 shares of the company’s stock worth $1,936,000 after acquiring an additional 10,539 shares during the period. Dynamic Technology Lab Private Ltd raised its stake in Zoetis by 7.3% during the second quarter. Dynamic Technology Lab Private Ltd now owns 5,901 shares of the company’s stock worth $368,000 after acquiring an additional 401 shares during the period. Finally, Advisory Services Network LLC raised its stake in Zoetis by 82.4% during the second quarter. Advisory Services Network LLC now owns 3,829 shares of the company’s stock worth $239,000 after acquiring an additional 1,730 shares during the period. Hedge funds and other institutional investors own 93.72% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.com-unik.info/2018/02/18/cantor-fitzgerald-reiterates-90-00-price-target-for-zoetis-zts.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.